[go: up one dir, main page]

TW200744616A - Drugs for treating cerebral infarction - Google Patents

Drugs for treating cerebral infarction

Info

Publication number
TW200744616A
TW200744616A TW095123003A TW95123003A TW200744616A TW 200744616 A TW200744616 A TW 200744616A TW 095123003 A TW095123003 A TW 095123003A TW 95123003 A TW95123003 A TW 95123003A TW 200744616 A TW200744616 A TW 200744616A
Authority
TW
Taiwan
Prior art keywords
salts
glycyrrhizin
drugs
cerebral infarction
treating cerebral
Prior art date
Application number
TW095123003A
Other languages
Chinese (zh)
Inventor
Yasunobu Antoku
Fumihiko Koike
Ryo Tanaka
Katsuhiro Ishibashi
Takashi Naito
Original Assignee
Yasunobu Antoku
Minophagen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yasunobu Antoku, Minophagen Pharmaceutical Co Ltd filed Critical Yasunobu Antoku
Publication of TW200744616A publication Critical patent/TW200744616A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/256—Polyterpene radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

The present invention relates to drugs for treating cerebral infarction containing glycyrrhizin and/or pharmaceutically acceptable salts of glycyrrhizin as the active ingredients. Ammonium salts of glycyrrhizin, alkali metallic salts of glycyrrhizin including sodium salt and potassium salt and so forth, or choline salts of glycyrrhizin can be preferably used. Furthermore, calcium salts, magnesium salts and aluminum salts and so forth can be used as the pharmaceutically acceptable salts in this invention.
TW095123003A 2005-06-28 2006-06-26 Drugs for treating cerebral infarction TW200744616A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005188876 2005-06-28

Publications (1)

Publication Number Publication Date
TW200744616A true TW200744616A (en) 2007-12-16

Family

ID=37595218

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095123003A TW200744616A (en) 2005-06-28 2006-06-26 Drugs for treating cerebral infarction

Country Status (2)

Country Link
TW (1) TW200744616A (en)
WO (1) WO2007000967A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106692086B (en) * 2016-12-12 2019-07-09 乐普药业股份有限公司 A kind of compound tablet of glycyrrhizin agent and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589182A (en) * 1993-12-06 1996-12-31 Tashiro; Renki Compositions and method of treating cardio-, cerebro-vascular and alzheimer's diseases and depression

Also Published As

Publication number Publication date
WO2007000967A1 (en) 2007-01-04

Similar Documents

Publication Publication Date Title
IL184898A0 (en) Pyrrolopyrimidine derivatives and pharmaceutical compositions containing the same
MX2009005413A (en) Crystalline forms of zoledronic acid.
MA34371B1 (en) CRYSTALLINE FORM OF SGL T2 INHIBITOR OF BENZYL-BENZENE TYPE
MY160703A (en) Crystalline forms of (r) -5- [3-chloro-4-(2,3-dihydroxy) - benz [z] ylidene] -2- ([z]-propylimino) -3-0-tolyl-thiazolidin-4-one
MY143795A (en) Tetrahydropyridoindole derivatives
NO20070155L (en) 5-Amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2H-pyrido [2,3-D] pyrimidine derivatives and related compounds for the treatment of cancer
TW200626157A (en) HCV inhibiting bi-cyclic pyrimidines
AR081579A1 (en) ELECTROLYTIC MIXTURES THAT PROVIDE A REDUCED SALT FLAVOR
TW200745124A (en) Azepinoindole derivatives as pharmaceutical agents
UA93709C2 (en) 12-imidazolyl-1-dodecanol and use thereof in the preparation of pharmaceutical compositions
NZ599265A (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
WO2008073332A3 (en) Creatine compositions for skin treatment
ZA201003380B (en) Improved pharmaceutical composition containing a pyrrolidone anticonvulsant agent and methhod for the preparation thereof
PH12017501397A1 (en) (2s, 4r)-5-(5`-chloro-2`-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid as neprilysin inhibitor
NO20074780L (en) Heterocyclylamide-substituted imidazoles
TN2010000585A1 (en) Pharmaceutical compositions of rosuvastatin calcium
MX370065B (en) (2r,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-met hyloxazole-2-carbonyl)amino]pentanoic acid.
MX2010003594A (en) Crystalline forms of dmxaa sodium salt.
TW200744616A (en) Drugs for treating cerebral infarction
TW200833708A (en) Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture
PH12018501876A1 (en) Crystalline(2s,4r)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof
RU2008139088A (en) REDUCED TITRATED ACID AND PREVENTION OF DENT AND DENTAL DEGENERATION
BRPI0509667A (en) Substituted azaquinazolines with antiviral efficacy
WO2010107791A3 (en) Pyrazinoisoquinoline compounds
TW200628468A (en) Bicyclononene derivatives